Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

Halloween drinks have become an art form, mixing spooky visuals with creative twists on classic recipes. From bubbling ...

Regeneron has once again received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the ...

Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending shares up 8 ...

The FDA has issued another complete response letter (CRL) to Regeneron, rejecting its bid for approval of its prefilled syringe version of high-dose (HD) Eylea—again for unresolved issues at the ...

Thinking about printing your own custom apparel? I put the Procolored F13 DTF printer, oven, and press package through its ...

Simtra BioPharma expands globally, advancing sterile injectable manufacturing and biopharma innovation through strategic partnerships.

The governor’s 14-point plan takes aim at some big-ticket items. But questions remain about how some of his ideas will be put ...

Safety initiatives in downtown Boston have produced some positive results over the past eight months — but business owners ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Stevanato Group S.p.A. continues expanding across global healthcare markets. The company strengthens its dual focus on biopharmaceutical solutions. Innovation and precision manufacturing support its ...

"So it means, and I don't mean this in a patronising way but there's a legacy which he's left. That being said, it shouldn't ...